BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16572838)

  • 21. Construction and immunogencity of a DeltaapxIC/DeltaapxIIC double mutant of Actinobacillus pleuropneumoniae serovar 1.
    Lin L; Bei W; Sha Y; Liu J; Guo Y; Liu W; Tu S; He Q; Chen H
    FEMS Microbiol Lett; 2007 Sep; 274(1):55-62. PubMed ID: 17608699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actinobacillus pleuropneumoniae RTX-toxins: uniform designation of haemolysins, cytolysins, pleurotoxin and their genes.
    Frey J; Bosse JT; Chang YF; Cullen JM; Fenwick B; Gerlach GF; Gygi D; Haesebrouck F; Inzana TJ; Jansen R
    J Gen Microbiol; 1993 Aug; 139(8):1723-8. PubMed ID: 8409915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Construction and characterization of Actinobacillus pleuropneumoniae serovar 7 live attenuated vaccine strain co-expressing ApxIA].
    Liu J; Chen Y; Hu L; Bei W; Chen H
    Sheng Wu Gong Cheng Xue Bao; 2010 Mar; 26(3):305-10. PubMed ID: 20518341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TurboID screening of ApxI toxin interactants identifies host proteins involved in Actinobacillus pleuropneumoniae-induced apoptosis of immortalized porcine alveolar macrophages.
    Hu Y; Jiang C; Zhao Y; Cao H; Ren J; Zeng W; Zhang M; Li Y; He Q; Li W
    Vet Res; 2023 Jul; 54(1):62. PubMed ID: 37475032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
    van den Bosch H; Frey J
    Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae.
    Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S
    Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of the role of antibodies to Actinobacillus pleuropneumoniae serovar 1 and 15 in the protection provided by sub-unit and live streptomycin-dependent pleuropneumonia vaccines.
    Tumamao JQ; Bowles RE; van den Bosch H; Klaasen HL; Fenwick BW; Blackall PJ
    Aust Vet J; 2004 Dec; 82(12):773-80. PubMed ID: 15648941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA.
    Shin SJ; Bae JL; Cho YW; Lee DY; Kim DH; Yang MS; Jang YS; Yoo HS
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):155-64. PubMed ID: 15681145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral immunization of mice with Saccharomyces cerevisiae expressing a neutralizing epitope of ApxIIA exotoxin from Actinobacillus pleuropneumoniae induces systemic and mucosal immune responses.
    Shin MK; Lee WJ; Jung MH; Cha SB; Shin SW; Yoo A; Kim DH; Yoo HS
    Microbiol Immunol; 2013 Jun; 57(6):417-25. PubMed ID: 23773020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71.
    Zhang F; Zhao Q; Quan K; Zhu Z; Yang Y; Wen X; Chang YF; Huang X; Wu R; Wen Y; Yan Q; Huang Y; Ma X; Han X; Cao S
    PLoS One; 2018; 13(6):e0198207. PubMed ID: 29856812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterisation of haemolytic RTX toxins produced by Australian isolates of Actinobacillus pleuropneumoniae.
    Tarigan S; Slocombe RF; Browning GF; Blackall PJ
    Aust Vet J; 1996 May; 73(5):164-9. PubMed ID: 8660237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of antigenic determinants in ApxIIA exotoxin capable of inducing protective immunity to Actinobacillus pleuropneumoniae challenge.
    Seo KW; Kim DH; Kim AH; Yoo HS; Lee KY; Jang YS
    Immunol Invest; 2011; 40(5):465-80. PubMed ID: 21425909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elucidating the role of ApxI in hemolysis and cellular damage by using a novel apxIA mutant of Actinobacillus pleuropneumoniae serotype 10.
    Chang NY; Chen ZW; Chen TH; Liao JW; Lin CC; Chien MS; Lee WC; Lin JH; Hsuan SL
    J Vet Sci; 2014; 15(1):81-9. PubMed ID: 23820218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and immunogenicity of a ∆apxIC/ompP2 mutant of Actinobacillus pleuropneumoniae and Haemophilus parasuis.
    Liu Q; Gong Y; Cao Y; Wen X; Huang X; Yan Q; Huang Y; Cao S
    Onderstepoort J Vet Res; 2013 Mar; 80(1):519. PubMed ID: 23718128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The RTX haemolysins ApxI and ApxII are major virulence factors of the swine pathogen Actinobacillus pleuropneumoniae: evidence from mutational analysis.
    Tascón RI; Vázquez-Boland JA; Gutiérrez-Martín CB; Rodríguez-Barbosa I; Rodríguez-Ferri EF
    Mol Microbiol; 1994 Oct; 14(2):207-16. PubMed ID: 7830567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. hlyIA-like sequence present in a genetic locus with low homology to appA in Actinobacillus pleuropneumoniae serotype 10.
    Nagai S; Takahashi K; Mitsui T; Yagihashi T
    J Vet Med Sci; 1993 Oct; 55(5):813-9. PubMed ID: 8286536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria.
    Lee KY; Kim DH; Kang TJ; Kim J; Chung GH; Yoo HS; Arntzen CJ; Yang MS; Jang YS
    FEMS Immunol Med Microbiol; 2006 Dec; 48(3):381-9. PubMed ID: 17054716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential use an Actinobacillus pleuropneumoniae double mutant strain DeltaapxIICDeltaapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals.
    Liu J; Chen X; Lin L; Tan C; Chen Y; Guo Y; Jin M; Guo A; Bei W; Chen H
    Vaccine; 2007 Nov; 25(44):7696-705. PubMed ID: 17767980
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Quan K; Zhu Z; Cao S; Zhang F; Miao C; Wen X; Huang X; Wen Y; Wu R; Yan Q; Huang Y; Ma X; Han X; Zhao Q
    J Microbiol Biotechnol; 2018 Dec; 28(12):2095-2105. PubMed ID: 30380823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of the znuA virulence factor attenuates Actinobacillus pleuropneumoniae and confers protection against homologous or heterologous strain challenge.
    Yuan F; Liao Y; You W; Liu Z; Tan Y; Zheng C; BinWang ; Zhou D; Tian Y; Bei W
    Vet Microbiol; 2014 Dec; 174(3-4):531-539. PubMed ID: 25465668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.